Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment

Two open-label, single-dose, parallel-group studies were conducted to characterize the pharmacokinetics of the novel antibacterial tedizolid and the safety of tedizolid phosphate, its prodrug, in renally or hepatically impaired subjects. Tedizolid pharmacokinetics in subjects with severe renal impai...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Flanagan, S., Minassian, S. L., Morris, D., Ponnuraj, R., Marbury, T. C., Alcorn, H. W., Fang, E., Prokocimer, P.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2014
Fag:
Pharmacology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249404/
https://ncbi.nlm.nih.gov/pubmed/25136024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03431-14
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker